Answers are grounded in this paper and cite their sources.
The results suggest FLIM could be a viable alternative to skin biopsies without the usual patient discomfort and limitations, thereby enabling the direct measurement of skin distribution through longitudinal monitoring. These results are the first step in establishing the unique capabilities that multiphoton imaging could provide to patients through noninvasive drug detection.
No takes yet. Share an insight, caveat, or question.
Alex et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: